Top Markets
Coin of the day
Abingdon Health Plc Abingdon Health Plc

Abingdon Health Plc

ABDX
株式のランク #39749
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a... Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately measuring kappa and lambda immunoglobulin free light chains in blood serum. Additionally, their AppDx technology converts any smartphone into an autonomous and adaptable lateral-flow reader. Beyond these offerings, the company provides expert services in lateral flow development and manufacturing, as well as advisory support to firms in the health tech industry. Abingdon Health Plc also engages in a collaborative and co-marketing partnership with Abcam plc.
株価
$0.14967717
時価総額
$378.31K
変化(1日)
4.76%
変化(1年)
77.02%
GB
取引 Abingdon Health Plc (ABDX)

カテゴリー

Abingdon Health Plc(ABDX)の利益
2026 時点の利益 TTM: 0
Abingdon Health Plc の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Abingdon Health Plc の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益